117 related articles for article (PubMed ID: 38100041)
21. Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX.
Thangaiyan R; Aljahdali IA; Lent-Moore KY; Liao J; Ling X; Li F
Am J Transl Res; 2021; 13(7):7458-7474. PubMed ID: 34377229
[TBL] [Abstract][Full Text] [Related]
22. An intravenous (i.v.) route-compatible formulation of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, improves FL118 antitumor efficacy and therapeutic index (TI).
Ling X; Li F
Am J Transl Res; 2013; 5(2):139-54. PubMed ID: 23573360
[TBL] [Abstract][Full Text] [Related]
23. Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?
Li F
Am J Cancer Res; 2014; 4(3):304-11. PubMed ID: 24959385
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
25. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.
Wang J; Liu Z; Zhang D; Liu R; Lin Q; Liu J; Yang Z; Ma Q; Sun D; Zhou X; Jiang G
Am J Transl Res; 2017; 9(8):3676-3686. PubMed ID: 28861158
[TBL] [Abstract][Full Text] [Related]
26. Discovery of survivin inhibitors and beyond: FL118 as a proof of concept.
Li F
Int Rev Cell Mol Biol; 2013; 305():217-52. PubMed ID: 23890383
[TBL] [Abstract][Full Text] [Related]
27. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
28. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities.
Ikeda T; Yaegashi T; Matsuzaki T; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Jan; 21(1):342-5. PubMed ID: 21126872
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitumor activity of novel substituted uracil-1'(N)-acetic acid ester derivatives of 20(S)-camptothecins.
Li DZ; Zhang QZ; Wang CY; Zhang YL; Li XY; Huang JT; Liu HY; Fu ZD; Song HX; Lin JP; Ji TF; Pan XD
Eur J Med Chem; 2017 Jan; 125():1235-1246. PubMed ID: 27871039
[TBL] [Abstract][Full Text] [Related]
30. Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
Santha S; Ling X; Aljahdali IAM; Rasam SS; Wang X; Liao J; Wang J; Fountzilas C; Li Q; Qu J; Li F
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217967
[TBL] [Abstract][Full Text] [Related]
31. Novel 7-substituted camptothecins with potent antitumor activity.
Dallavalle S; Delsoldato T; Ferrari A; Merlini L; Penco S; Carenini N; Perego P; De Cesare M; Pratesi G; Zunino F
J Med Chem; 2000 Oct; 43(21):3963-9. PubMed ID: 11052801
[TBL] [Abstract][Full Text] [Related]
32. Uptake and efflux of FL118 and two FL118 derivatives in 3D cell model.
Zhou L; Weng Q; Zheng Y; Zhou Y; Li Q; Li F
Cytotechnology; 2019 Jul; 71(4):785-795. PubMed ID: 31309350
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities.
Shan WG; Wang HG; Chen Y; Wu R; Wen YT; Zhang LW; Ying YM; Wang JW; Zhan ZJ
Bioorg Med Chem Lett; 2017 Aug; 27(15):3450-3453. PubMed ID: 28587825
[TBL] [Abstract][Full Text] [Related]
34. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of novel PEG-conjugated 20(S)-camptothecin sulfonylamidine derivatives with potent in vitro antitumor activity via Cu-catalyzed three-component reaction.
Song ZL; Chen HL; Wang YH; Goto M; Gao WJ; Cheng PL; Morris-Natschke SL; Liu YQ; Zhu GX; Wang MJ; Lee KH
Bioorg Med Chem Lett; 2015 Jul; 25(13):2690-3. PubMed ID: 25987370
[TBL] [Abstract][Full Text] [Related]
36. Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor Activity.
Lu B; Liu D; Gui B; Gou J; Dong H; Hu Q; Feng J; Mao Y; Shen X; Wang S; Zhang C; Shen R; Yan Y; Chen L; Wang H; Li D; Zhang J; Zhang M; Zhang R; Bai C; He F; Tao W; Liu S
J Med Chem; 2021 Oct; 64(20):14983-14996. PubMed ID: 34643383
[TBL] [Abstract][Full Text] [Related]
37. Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy.
Zhang Y; Yin R; Wu G; Yu M; Liu J; Wang X; Liu X; Guan H; Yu R; Jiang T
Eur J Med Chem; 2020 Aug; 200():112365. PubMed ID: 32460113
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of new 7-(N-substituted-methyl)-camptothecin derivatives as potent cytotoxic agents.
Zhao XB; Goto M; Song ZL; Morris-Natschke SL; Zhao Y; Wu D; Yang L; Li SG; Liu YQ; Zhu GX; Wu XB; Lee KH
Bioorg Med Chem Lett; 2014 Aug; 24(16):3850-3. PubMed ID: 25008456
[TBL] [Abstract][Full Text] [Related]
39. Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models.
Reipsch F; Biersack B; Lucas H; Schobert R; Mueller T
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884888
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of novel 7-[(
Song ZL; Yang GZ; Li JC; Liu YQ; Yang CJ; Goto M; Zhang ZJ; Morris-Natschke SL; Liu H; Lee KH
Nat Prod Res; 2020 Jul; 34(14):2022-2029. PubMed ID: 30784310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
